Oddo BHF - Pierre Vacances SA (VAC) Pierre Vacances : ROC S1 sous les attentes, pÃ©nalisÃ© par lâ€™Immobilier et Village Nature. TP abaissÃ© Ã 48â‚¬

Report

Oddo BHF

Pierre & Vacances : ROC S1 sous les attentes, pÃ©nalisÃ© par lâ€™Immobilier et Village Nature. TP abaissÃ© Ã 48â‚¬

>ROC S1 de -94.9Mâ‚¬ (vs. -81.9Mâ‚¬e) soit +1.1Mâ‚¬ yoy - Au titre du S1 (sept-mars), le groupe Pierre&Vacances publie des rÃ©sultats infÃ©rieurs Ã nos attentes. Pour un CA dÃ©jÃ publiÃ© de 654.8Mâ‚¬ (+6.5% yoy), le ROC sâ€™Ã©tablit Ã -94.9Mâ‚¬, en amÃ©lioration yoy de 1.1Mâ‚¬, mais infÃ©rieur Ã nos attentes (-80.4Mâ‚¬e), avec le Tourisme Ã -86.4Mâ‚¬ et lâ€™Immobilier Ã -8.5Mâ‚¬.Notamment aprÃ¨s prise en compte dâ€™un rÃ©sultat financier de -8Mâ‚¬ (en ligne avec nos attentes), de -1.1Mâ‚¬ de one off...

31/05/2018 4 FR

Underlying

Pierre & Vacances SA

Pierre & Vacances is engaged in the market of local tourism by operating apartments and homes, or beds, located primarily in France (in mountain, seaside and countryside resorts, cities and the French West Indies), as well as in the Netherlands, Germany, Belgium, Italy and Spain. Co. develops its activities through two lines of business: the Property Development business (building and marketing of the residences and villages in France, Italy and Spain) and the Tourism business (operating and marketing of holidays in residences and villages under the Pierre & Vacances, Maeva, Adagio, Residences MGM, Hotels Latitudes, Center Parcs Europe and Sunparks brands).

See profile

FR0000073041 Euronext Paris France

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Other Reports on these Companies

BusinessWire

Pierre & Vacances-Center Parcs : Nombre total d’actions et de droits de vote

PARIS--(BUSINESS WIRE)-- Regulatory News: Pierre & Vacances-Center Parcs (Paris:VAC): Date Nombre d’actions Nombre de droits de vote bruts (droits théoriques) Nombre de droits de vote nets (exerçables en AG) (*) 31 mars 2024 454 447 336 454 447 336 454 297 632 (*) Déduction faite des actions auto-détenues privées de droit de vote et des 1.188 ADP dépourvues de droit de vote. Consultez la version source sur businesswire.com :

April 5, 2024 April 5, 2024 1 FR

BusinessWire

Pierre & Vacances-Center Parcs : Nombre total d’actions et de droits de vote

PARIS--(BUSINESS WIRE)-- Regulatory News: Pierre & Vacances-Center Parcs (Paris:VAC): Date Nombre d’actions Nombre de droits de vote bruts (droits théoriques) Nombre de droits de vote nets (exerçables en AG) (*) 29 février 2024 454 442 381 454 442 381 454 292 677 (*) Déduction faite des actions auto-détenues privées de droit de vote et des 1.103 ADP dépourvues de droit de vote. PIERRE ET VACANCES Société anonyme au capital de 4.544.383,72 euros Siège social : L’Artois – 11 rue de Cambrai – 75947 Paris Cedex 19 316 580 869 R.C.S. Paris ...

March 8, 2024 March 8, 2024 1 FR

BusinessWire

Pierre & Vacances-Center Parcs : Nombre total d’actions et de droits de vote

PARIS--(BUSINESS WIRE)-- Regulatory News: Pierre & Vacances-Center Parcs Date Nombre d’actions Nombre de droits de vote bruts (droits théoriques) Nombre de droits de vote nets (exerçables en AG) (*) 31 janvier 2024 454 436 701 454 436 701 454 287 264 (*) Déduction faite des actions auto-détenues privées de droit de vote et des 1.103 ADP dépourvues de droit de vote. PIERRE ET VACANCES Société anonyme au capital de 4.544.371,28 euros Siège social : L’Artois – 11 rue de Cambrai – 75947 Paris Cedex 19 316 580 869 R.C.S. Paris Consultez la...

February 7, 2024 February 7, 2024 1 FR

Novartis : Excellent T1 justifiant un relèvement de guidance FY

>T1 au-dessus des attentes sur la topline (+4%) et la bottom line (+7%) - Le T1 ressort au-dessus des attentes au niveau des ventes (+4% vs Css) et du core BPA (+7% vs Css). Les ventes progressent de 11% tcc (10% en publié) tirées par tous les produits phares : Entresto (34%, +15% vs Css), Cosentyx (23%, 10% vs Css), Kisqali (51%, -2% vs Css) et Kesimpta (66%, 0% vs Css). Notons que Pluvicto (47%, -3% vs Css) ressort une nouvelle fois légèrement en dessous des attente...

7m 7m 1 FR

Nicolas David

Nicolas David

SAP : A good start to the year, but not enough (and too early) to raise guidance

>Solid Cloud & Software revenue, driven by on-premises resilience. Strong CCB - SAP released its Q1 2024 earnings yesterday after market. Sales were just in line, at € 8.04bn (css: € 8.02bn) but Cloud & Software revenue growth on cc came in at 11%, above expectations (css: 9% cc), thanks, again, to impressive resilience from the Support revenues (-1% cc vs css: -2.8% cc), while Cloud revenue growth was just in line with expectations (25% cc). The current Cloud backlo...

13m 13m 1 EN

Oliver Metzger ... (+2)

Oliver Metzger
Stephan Wulf

Dermapharm Holding SE : Smooth integration of Arkopharma and declining leverage should support share price performance

>2023 net earnings also burdened by accounting-related charges - While the final sales and EBITDA figures confirmed the preliminary results released on 14 March, the net result for 2023 published for the first time obviously led to disappointment in the market. The significant increase in financial expenses (c +400% to € 73m), together with the lower operating result (-25%) due to the absence of the vaccine business, led to a significantly lower net result of € 60.5m ...

25m 25m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Pierre & Vacances : ROC S1 sous les attentes, pÃ©nalisÃ© par lâ€™Immobilier et Village Nature. TP abaissÃ© Ã 48â‚¬

Pierre & Vacances-Center Parcs : Nombre total d’actions et de droits de vote

Pierre & Vacances-Center Parcs : Nombre total d’actions et de droits de vote

Pierre & Vacances-Center Parcs : Nombre total d’actions et de droits de vote

Novartis : Excellent T1 justifiant un relèvement de guidance FY

SAP : A good start to the year, but not enough (and too early) to raise guidance

Dermapharm Holding SE : Smooth integration of Arkopharma and declining leverage should support share price performance

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe